Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid Cancer.
Thyroid
; 28(9): 1174-1179, 2018 09.
Article
in En
| MEDLINE
| ID: mdl-30105951
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Morpholines
/
Adenocarcinoma, Follicular
/
Enzyme Inhibitors
/
Thyroid Cancer, Papillary
/
Phosphoinositide-3 Kinase Inhibitors
/
Aminopyridines
/
Antineoplastic Agents
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Thyroid
Journal subject:
ENDOCRINOLOGIA
Year:
2018
Type:
Article
Affiliation country:
France